Mechanisms of gelsolin-dependent and -independent EGF-stimulated cell motility in a human lung epithelial cell line

Experimental Cell Research

Volumn 307, Issue 1, 2005, Pages 153-163

  Lader, Alan S ^a,b   Lee, Justin J ^a   Cicchetti, Gregor ^a,b   Kwiatkowski, David J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

EGF; Gelsolin; Motility; PDGF; Phosphatidylinositol 3 kinase; Phospholipase C

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBRONECTIN; GELSOLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR;

ARTICLE; BRONCHUS MUCOSA; CELL MOTILITY; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; METASTASIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 19544392133     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.03.001     Document Type: Article

References (50)

1. A. Jemal, R.C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, E. Ward, E.J. Feuer, and M.J. Thun Cancer statistics, 2004 CA Cancer J. Clin. 54 2004 8 29
2. J.H. Schiller, D. Harrington, C.P. Belani, C. Langer, A. Sandler, J. Krook, J. Zhu, and D.H. Johnson Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N. Engl. J. Med. 346 2002 92 98
3. R.G. McKinnell, R.E. Parchment, A.O. Perantoni, and G.B. Pierce The Biological Basis of Cancer 1998 Cambridge Univ. Press New York
4. R. Warn, D. Brown, P. Dowrick, A. Prescott, and A. Warn Cytoskeletal changes associated with cell motility Symp. Soc. Exp. Biol. 47 1993 325 338
5. A.A. Schmitz, E.E. Govek, B. Bottner, and L. Van Aelst Rho GTPases: signaling, migration, and invasion Exp. Cell Res. 261 2000 1 12
6. M. Tanaka, L. Mullauer, Y. Ogiso, H. Fujita, S. Moriya, K. Furuuchi, T. Harabayashi, N. Shinohara, T. Koyanagi, and N. Kuzumaki Gelsolin: a candidate for suppressor of human bladder cancer Cancer Res. 55 1995 3228 3232
7. H.K. Lee, D. Driscoll, H. Asch, B. Asch, and P.J. Zhang Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate Prostate 40 1999 14 19
8. H.L. Asch, K. Head, Y. Dong, F. Natoli, J.S. Winston, J.L. Connolly, and B.B. Asch Widespread loss of gelsolin in breast cancers of humans, mice, and rats Cancer Res. 56 1996 4841 4845
9. J.S. Winston, H.L. Asch, P.J. Zhang, S.B. Edge, A. Hyland, and B.B. Asch Downregulation of gelsolin correlates with the progression to breast carcinoma Breast Cancer Res. Treat. 65 2001 11 21
10. H. Dosaka-Akita, F. Hommura, H. Fujita, I. Kinoshita, M. Nishi, T. Morikawa, H. Katoh, Y. Kawakami, and N. Kuzumaki Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers Cancer Res. 58 1998 322 327
11. D.B. Shieh, J. Godleski, J.E. Herndon II, T. Azuma, H. Mercer, D.J. Sugarbaker, and D.J. Kwiatkowski Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression Cancer 85 1999 47 57
12. W. Witke, A.H. Sharpe, J.H. Hartwig, T. Azuma, T.P. Stossel, and D.J. Kwiatkowski Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin Cell 81 1995 41 51
13. C.C. Cunningham, T.P. Stossel, and D.J. Kwiatkowski Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin Science 251 1991 1233 1236
14. T. Azuma, W. Witke, T.P. Stossel, J.H. Hartwig, and D.J. Kwiatkowski Gelsolin is a downstream effector of rac for fibroblast motility EMBO J. 17 1998 1362 1370
15. P. Chen, J.E. Murphy-Ullrich, and A. Wells A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility J. Cell Biol. 134 1996 689 698
16. C. Chaponnier, O. Kocher, and G. Gabbiani Modulation of gelsolin content in rat aortic smooth muscle cells during development, experimental intimal thickening and culture. An immunohistochemical and biochemical study Eur. J. Biochem. 190 1990 559 565
17. H. Fujita, F. Okada, J. Hamada, M. Hosokawa, T. Moriuchi, R.C. Koya, and N. Kuzumaki Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect Int. J. Cancer 93 2001 773 780
18. J.H. Schiller, and G. Bittner Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction Cancer Res. 55 1995 6215 6221
19. J.H. Schiller, G. Bittner, S.Q. Wu, and L. Meisner Karyotypic changes associated with spontaneous acquisition and loss of tumorigenicity in a human transformed bronchial epithelial cell line: evidence for in vivo selection of transformed clones In Vitro Cell Dev. Biol. Anim. 34 1998 283 289
20. J.L. Wittenkeller, B. Storer, G. Bittner, and J.H. Schiller Comparison of spontaneous and induced mutation rates in an immortalized human bronchial epithelial cell line and its tumorigenic derivative Oncology 54 1997 335 341
21. J. Banyard, B. Anand-Apte, M. Symons, and B.R. Zetter Motility and invasion are differentially modulated by Rho family GTPases Oncogene 19 2000 580 591
22. N. Koshikawa, G. Giannelli, V. Cirulli, K. Miyazaki, and V. Quaranta Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5 J. Cell Biol. 148 2000 615 624
23. Q. Meng, M. Qi, D.Z. Chen, R. Yuan, I.D. Goldberg, E.M. Rosen, K. Auborn, and S. Fan Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes J. Mol. Med. 78 2000 155 165
24. M. Mukai, F. Imamura, M. Ayaki, K. Shinkai, T. Iwasaki, K. Murakami-Murofushi, H. Murofushi, S. Kobayashi, T. Yamamoto, H. Nakamura, and H. Akedo Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA) Int. J. Cancer 81 1999 918 922
25. 2+-independent pathways J. Exp. Med. 165 1987 97 106
26. P. Chen, H. Xie, M.C. Sekar, K. Gupta, and A. Wells Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement J. Cell Biol. 127 1994 847 857
27. M.J. Berridge Inositol triphosphate and calcium signaling Nature 361 1993 315 325
28. D.J. Kwiatkowski, and H.L. Yin Molecular biology of gelsolin, a calcium-regulated actin filament severing protein Biorheology 24 1987 643 647
29. A. Mancini, A. Koch, R. Wilms, and T. Tamura The SH2-containing inositol 5-phosphatase (SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells Oncogene 21 2002 1477 1484
30. J. Meisenhelder, P.G. Suh, S.G. Rhee, and T. Hunter Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro Cell 57 1989 1109 1122
31. N. Pouliot, E.C. Nice, and A.W. Burgess Laminin-10 mediates basal and EGF-stimulated motility of human colon carcinoma cells via alpha(3)beta(1) and alpha(6)beta(4) integrins Exp. Cell Res. 266 2001 1 10
32. J.W. Lee, and R.L. Juliano The alpha5beta1 integrin selectively enhances epidermal growth factor signaling to the phosphatidylinositol-3-kinase/Akt pathway in intestinal epithelial cells Biochim. Biophys. Acta 1542 2002 23 31
33. B. Anand-Apte, and B.R. Zetter Signaling mechanisms in growth factor-stimulated cell motility Stem Cells 15 1997 259 267
34. G. Carpenter, and Q.-S. Ji Phospolipase C-gamma as a signal transducing element Exp. Cell Res. 253 1999 15 24
35. K. Inukai, M. Funaki, M. Anai, T. Ogihara, H. Katagiri, Y. Fukushima, H. Sakoda, Y. Onishi, H. Ono, M. Fujishiro, M. Abe, Y. Oka, M. Kikuchi, and T. Asano Five isoforms of the phosphatidylinositol 3-kinase regulatory subunit exhibit different associations with receptor tyrosine kinases and their tyrosine phosphorylations FEBS Lett. 490 2001 32 38
36. J.D. Hood, and D.A. Cheresh Role of integrins in cell invasion and migration Nat. Rev., Cancer 2 2002 91 100
37. L. Mauro, D. Sisci, M. Bartucci, M. Salerno, J. Kim, T. Tam, M.A. Guvakova, S. Ando, and E. Surmacz SHC-alpha5beta1 integrin interactions regulate breast cancer cell adhesion and motility Exp. Cell Res. 252 1999 439 448
38. J. Li, M.L. Lin, G.J. Wiepz, A.G. Guadarrama, and P.J. Bertics Integrin-mediated migration of murine B82L fibroblasts is dependent on the expression of an intact epidermal growth factor receptor J. Biol. Chem. 274 1999 11209 11219
39. K. Krensel, and R.B. Lichtner Selective increase of alpha2-integrin sub-unit expression on human carcinoma cells upon EGF-receptor activation Int. J. Cancer 80 1999 546 552
40. L. Moro, L. Dolce, S. Cabodi, E. Bergatto, E.B. Erba, M. Smeriglio, E. Turco, S.F. Retta, M.G. Giuffrida, M. Venturino, J. Godovac-Zimmermann, A. Conti, E. Schaefer, L. Beguinot, C. Tacchetti, P. Gaggini, L. Silengo, G. Tarone, and P. Defilippi Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines J. Biol. Chem. 277 2002 9405 9914
41. D.J. Sieg, C.R. Hauck, D. Ilic, C.K. Klingbeil, E. Schaefer, C.H. Damsky, and D.D. Schlaepfer FAK integrates growth-factor and integrin signals to promote cell migration Nat. Cell Biol. 2 2000 249 256
42. V. De Corte, E. Bruyneel, C. Boucherie, M. Mareel, J. Vandekerckhove, and J. Gettemans Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling EMBO J. 21 2002 6781 6790
43. T. Azuma, K. Koths, L. Flanagan, and D. Kwiatkowski Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression J. Biol. Chem. 275 2000 3761 3766
44. S. Kothakota, T. Azuma, C. Reinhard, A. Klippel, J. Tang, K. Chu, T.J. McGarry, M.W. Kirschner, K. Koths, D.J. Kwiatkowski, and L.T. Williams Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis Science 278 1997 294 298
45. Y.J. Geng, T. Azuma, J.X. Tang, J.H. Hartwig, M. Muszynski, Q. Wu, P. Libby, and D.J. Kwiatkowski Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines Eur. J. Cell Biol. 77 1998 294 302
46. H. Sun, K. Lin, and H.L. Yin Gelsolin modulates phospholipase C activity in vivo through phospholipid binding J. Cell Biol. 138 1997 811 820
47. N. Sagawa, H. Fujita, Y. Banno, Y. Nozawa, H. Katoh, and N. Kuzumaki Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10 Br. J. Cancer 88 2003 606 612
48. A. Sazawa, T. Watanabe, M. Tanaka, K. Haga, H. Fujita, T. Harabayashi, N. Shinohara, T. Koyanagi, and N. Kuzumaki Adenovirus mediated gelsolin gene therapy for orthotopic human bladder cancer in nude mice J. Urol. 168 2002 1182 1187
49. M. Tanaka, A. Sazawa, N. Shinohara, Y. Kobayashi, Y. Fujioka, T. Koyanagi, and N. Kuzumaki Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice Cancer Gene Ther. 6 1999 482 487
50. A.D. Thor, S.M. Edgerton, S. Liu, D.H. Moore II, and D.J. Kwiatkowski Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers Clin. Cancer Res. 7 2001 2415 2424